MAP2K3 and esophageal squamous cell carcinoma: However, MAP2K3(S‐A) abolished the antitumor effect, suggesting that Ser‐189 and Thr‐193 phosphorylation sites affect MAP2K3’s function on cell proliferation and invasion in ESCC.